| Literature DB >> 34914062 |
Sunil Kumar1, Shubhranshu Zutshi1, Mukesh Kumar Jha1,2, Prashant Chauhan1, Bhaskar Saha3,4.
Abstract
Search for an efficacious antileishmanial vaccine has led to clinical trials of numerous vaccine candidates in the past few decades. As no promising candidate has emerged from these studies, novel vaccine modalities and vaccine assessment techniques are still emerging for antileishmanial vaccine development. Briefly, this chapter discusses: (a) history and timeline of antileishmanial vaccine development; (b) techniques utilized for developing whole-parasite and subunit-based antileishmanial vaccine formulations, and (c) immunogenicity and post-challenge protective efficacy assessment of vaccine candidates.Entities:
Keywords: Antileishmanial vaccine; Electroporation; Flow cytometry; Immunogenicity; Mass spectrometry; Ni-NTA affinity chromatography; Parasite load; T-helper response
Mesh:
Substances:
Year: 2022 PMID: 34914062 DOI: 10.1007/978-1-0716-1884-4_23
Source DB: PubMed Journal: Methods Mol Biol ISSN: 1064-3745